Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma

Esther Drent, Richard W. J. Groen, Willy A. Noort, Maria Themeli, Jeroen J. Lammerts van Bueren, Paul W. H. I. Parren, Jurgen Kuball, Zsolt Sebestyen, Huipin Yuan, Joost de Bruijn, Niels W. C. J. van de Donk, Anton C. M. Martens, Henk M. Lokhorst, Tuna Mutis

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)616-625
JournalHaematologica
Volume101
Issue number5
DOIs
Publication statusPublished - May 2016

Cite this

Drent, Esther ; Groen, Richard W. J. ; Noort, Willy A. ; Themeli, Maria ; van Bueren, Jeroen J. Lammerts ; Parren, Paul W. H. I. ; Kuball, Jurgen ; Sebestyen, Zsolt ; Yuan, Huipin ; de Bruijn, Joost ; van de Donk, Niels W. C. J. ; Martens, Anton C. M. ; Lokhorst, Henk M. ; Mutis, Tuna. / Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma. In: Haematologica. 2016 ; Vol. 101, No. 5. pp. 616-625.
@article{c80fd0e419244da894b26ef8cfae037c,
title = "Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma",
author = "Esther Drent and Groen, {Richard W. J.} and Noort, {Willy A.} and Maria Themeli and {van Bueren}, {Jeroen J. Lammerts} and Parren, {Paul W. H. I.} and Jurgen Kuball and Zsolt Sebestyen and Huipin Yuan and {de Bruijn}, Joost and {van de Donk}, {Niels W. C. J.} and Martens, {Anton C. M.} and Lokhorst, {Henk M.} and Tuna Mutis",
year = "2016",
month = "5",
doi = "10.3324/haematol.2015.137620",
language = "English",
volume = "101",
pages = "616--625",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "5",

}

Drent, E, Groen, RWJ, Noort, WA, Themeli, M, van Bueren, JJL, Parren, PWHI, Kuball, J, Sebestyen, Z, Yuan, H, de Bruijn, J, van de Donk, NWCJ, Martens, ACM, Lokhorst, HM & Mutis, T 2016, 'Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma' Haematologica, vol. 101, no. 5, pp. 616-625. https://doi.org/10.3324/haematol.2015.137620

Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma. / Drent, Esther; Groen, Richard W. J.; Noort, Willy A.; Themeli, Maria; van Bueren, Jeroen J. Lammerts; Parren, Paul W. H. I.; Kuball, Jurgen; Sebestyen, Zsolt; Yuan, Huipin; de Bruijn, Joost; van de Donk, Niels W. C. J.; Martens, Anton C. M.; Lokhorst, Henk M.; Mutis, Tuna.

In: Haematologica, Vol. 101, No. 5, 05.2016, p. 616-625.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma

AU - Drent, Esther

AU - Groen, Richard W. J.

AU - Noort, Willy A.

AU - Themeli, Maria

AU - van Bueren, Jeroen J. Lammerts

AU - Parren, Paul W. H. I.

AU - Kuball, Jurgen

AU - Sebestyen, Zsolt

AU - Yuan, Huipin

AU - de Bruijn, Joost

AU - van de Donk, Niels W. C. J.

AU - Martens, Anton C. M.

AU - Lokhorst, Henk M.

AU - Mutis, Tuna

PY - 2016/5

Y1 - 2016/5

U2 - 10.3324/haematol.2015.137620

DO - 10.3324/haematol.2015.137620

M3 - Article

VL - 101

SP - 616

EP - 625

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 5

ER -